A Big Pharma-funded charity that helps patients pay for drugs just sued the government image

Washington Post, January 8, 2018
Carolyn Y. Johnson, quoting Christopher T. Robertson (Academic Fellow Alumnus)


Read the full article

From the article:

These charities help patients out, but they also provide a lucrative philanthropic option for donors. Drug companies get reimbursed by government health programs or private insurers, and defuse potential criticism from sick people who can’t afford their drugs. A Citi Research report from 2017 found that every $1 million the drug industry spends on charitable donations to support access to high-priced drugs has the potential to generate up to $21 million for the sponsor company.


“The companies get a huge recycling of money through this process,” said Christopher Robertson, associate dean for research and innovation at the University of Arizona. “If you start adding in the tax deductibility [of donations], it’s obviously a good business strategy.”


Read more here!

bioethics health law policy pharmaceuticals regulation